Brief: Caplin Point Laboratories says Caplin Steriles Receives EIR From FDA

Caplin Point Laboratories

04/09/2023 07:28

Sept 4 (Reuters) - Caplin Point Laboratories Ltd
 CAPL.NS :
    * CAPLIN STERILES RECEIVES EIR FROM US FDA
    * EIR RECEIVED FOR UNIT'S INJECTABLE AND OPHTHALMIC
MANUFACTURING
UNIT LOCATED AT GUMMIDIPOONDI, CHENNAI
    * UNIT UNDERWENT AN INSPECTION FROM US FDA DURING MAY 22ND -
MAY
31ST
    * INSPECTION CLASSIFICATION WAS DETERMINED BY AGENCY AS
VOLUNTARY
ACTION INDICATED

Source text for Eikon:  ID:nBSE2pVj8W 
Further company coverage:  CAPL.NS 

 ((Reuters.Briefs@thomsonreuters.com;))